Jin-Heung Sung

Title: Innovator Spotlight: Jin-Heung Sung and His Groundbreaking Pharmaceutical Patent

Introduction: Jin-Heung Sung, an inventive force in the pharmaceutical industry, hails from Bucheon-si, South Korea. With a keen focus on stability and efficacy, he has made significant strides in the formulation of injection-based medicines.

Latest Patents: His most notable patent is a stable pharmaceutical composition containing docetaxel, along with a method for its manufacturing. This innovation addresses the challenges faced with conventional medications by providing a pharmaceutical composition for injection that boasts enhanced storage stability. The process involves dissolving docetaxel, a notoriously water-insoluble compound, in distilled water, combined with cyclodextrin and a water-soluble polymer, such as hydroxypropyl methylcellulose (HPMC), polyethylene glycol (PEG), or polyvinylpyrrolidone (PVP), followed by lyophilization. This method not only improves the drug's stability but also enhances its potential efficacy.

Career Highlights: Currently, Jin-Heung Sung is employed at Sk Chemicals Co., Ltd., where he contributes his expertise and innovative mindset to the development of cutting-edge pharmaceutical products. His singular patent exemplifies his commitment to advancing the field of medicine through practical and inventive solutions.

Collaborations: Throughout his career, Jin-Heung has had the privilege of working alongside talented individuals such as Nam Ho Kim and Jin Young Lee. Their collaborative efforts have likely propelled innovations and facilitated a dynamic work environment focused on pharmaceutical research and development.

Conclusion: Jin-Heung Sung’s contribution to the pharmaceutical industry through his patent on a stable docetaxel composition highlights his role as a forward-thinking inventor. His work at Sk Chemicals Co., Ltd. not only exemplifies individual achievement but also reflects the importance of collaboration in driving innovation within the pharmaceutical sector.